Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s New Criminal Investigations Chief Wants Global Reach

Executive Summary

Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in interview with “The Pink Sheet.”

You may also be interested in...



FDA Posts Investigator In Singapore, But Trims Foreign Office List

FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA is shifting from a predominantly domestic focus to global as drug criminal organizations spread worldwide,

FDA Posts Investigator In Singapore, But Trims Foreign Office List

FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally

FDA Posts OCI Agent In Singapore, But Other Foreign Offices Close

China offices consolidate to allow FDA to 'strategically focus its resources.'

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS056734

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel